✦ LIBER ✦

Pricing dynamics and product quality: the case of antidepressant drugs

✍ Scribed by Jie Chen; John A. Rizzo

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 294 KB
Volume: 42
Category: Article
ISSN: 0377-7332
DOI: 10.1007/s00181-010-0426-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of antidepressant drugs: the

Combination of antidepressant drugs: the case of inositol

✍ Boris Nemets; Mendel Fux; Joseph Levine; R. H Belmaker 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Inositol is a second messenger precursor that is effective in depression and obsessive-compulsive disorder via a mechanism different from serotonin reuptake inhibitors. However, controlled trials of inositol combined with serotonin reuptake inhibitors in depression or in reuptake inhibitor resistant

Regional productivity and relative price

Regional productivity and relative prices dynamics: the case of Italy

✍ Carla Massidda; Paolo Mattana 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 321 KB

On the distribution of product price and

On the distribution of product price and quality

✍ Alex Coad 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 414 KB

Product quality, attributes, and brand n

Product quality, attributes, and brand name as determinants of price: The case of consumer electronics

✍ Morris B. Holbrook 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 827 KB

Chemoprevention: Drug pricing and mortal

Chemoprevention: Drug pricing and mortality : The case of tamoxifen

✍ Joy Melnikow; Christina Kuenneth; L. Jay Helms; Amber Barnato; Miriam Kuppermann 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Regulation and the provision of quality

Regulation and the provision of quality to heterogenous consumers: The case of prospective pricing of medical services

✍ Robin Allen; Paul Gertler 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 919 KB

This paper analyzes the welfare implications of fixed-price regulation of services in a model in which consumers are heterogenous and a firm can endogenously quality discriminate. We consider two different scenarios: The first scenario is when the consumer is also the payer. The second scenario is w